Aerosol Delivery in the Treatment of Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|15|7|604-612

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.7, 2015-01, pp. : 604-612

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel (Taxol) and Taxoid Derivates for Lung Cancer Treatment: Potential for Aerosol Delivery

By  

Current Cancer Drug Targets, Vol. 3, Iss. 4, 2003-01 ,pp. : 287-296

Bentham Science Publishers

Access to resources Recommend Favorite

Camptothecins and Lung Cancer: Improved Delivery Systems by Aerosol

By  

Current Cancer Drug Targets, Vol. 3, Iss. 4, 2003-08 ,pp. : 251-264

Bentham Science Publishers

Access to resources Recommend Favorite

The Re-Emergence of Aerosol Gene Delivery: A Viable Approach to Lung Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 3, Iss. 4, 2003-08 ,pp. : 275-286

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Lung Cancer Using Nanoparticle Drug Delivery Systems

By  

Current Drug Discovery Technologies, Vol. 10, Iss. 2, 2013-06 ,pp. : 170-176

Bentham Science Publishers

Access to resources Recommend Favorite

Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections

By Togami Kohei   Chono Sumio   Seki Toshinobu   Morimoto Kazuhiro  

Drug Development and Industrial Pharmacy, Vol. 36, Iss. 7, 2010-07 ,pp. : 861-866

Informa Healthcare

Access to resources Recommend Favorite